Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar MikeJones55 (33.89) Submitted: 7/20/2012 8:33:08 AM : Outperform Start Price: $26.84 GILD Score: +87.86

bought two months ago at 46.96 and forgot to log it here. Bought primarily due to SA recommendation

Featured Broker Partners


Advertisement